Keywords
coxarthrosis
hip osteoarthritis
viscosupplementation
infiltration
intra-articular injection
ultrasound guide.
Abstract
Introduction: Ultrasound-guided viscosupplementation with hyaluronic acid in symptomatic hip osteoarthritis is widely used as a safe treatment with proven efficacy, although there is a lack of consensus on its use as routine practice. Few studies have compared the efficacy of two single injection products. Objetive: To evaluate the efficacy in infiltrated patients with two single injection hyaluronic acids comparing Adant One® (A) at six months with annual Hyalone® (H). Material and method: Restrospective observational study on a cohort of patients with symptomatic hip osteoarthritis, treated by ultrasound-guided intra-articular viscossuplementation with two types of single injection of hyaluronic acid. Its efficacy was evaluated according to the WOMAC and VAS scales at 6 and 12 months. Results: 144 patients were treated with a single dose of A and 84 with H. At 6 months, those treated with A showed improvements in relation to pain reduction in the VAS (p < 0.001) and in the WOMAC pain (p = 0.003), as well as in global WOMAC (p = 0.027). There were no changes in WOMAC stiffness and function. At 12 months, those treated with H showed significant improvements in the VAS (p < 0.001) and global WOMAC (p = 0.010) parameters and in all their dimensions. Conclusions: A single injection of annual H was more effective in improving pain and function of the hip with osteoarthritis at 1 year compared to A at 6 months. It is possible to establish annual viscossuplementation protocols for hip osteoarthritis with hyaluronic acid using H.References
1. Acuña AJ, Samuel LT, Jeong SH, Emara AK, Kamath AF. Viscosupplementation for hip osteoarthritis: Does systematic review of patient-reported outcome measures support use? J Orthop. 2020;21:137-49.
2. De Lucía O, Pierannunzii LM, Pregnolato F, Verduci E, Crotti C, Valcamonica E, et al. Effectiveness and tolerability of repeated courses of viscosupplementation on symptomatic hip osteoarthritis: A retrospective observational cohort study of high molecular weight vs medim molecular weight hyaluronic acid vs no viscosupplementation. Front Pharmacol. 2019;10:1007.
3. Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 America College of Rheumatology/Arthritis Foundation Guideline for the management of osteoarthritis of the hand, hip and knee. Arthritis Care Res (Hoboken). 2020;72(2):149-62.
4. Zhang W, Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476-99.
5. Conrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D, et al. EUROVISCO Recommendations for optimizing the clinical results of viscosupplementation in osteoarthritis. Cartilage. 2020;11(1):47-59.
6. De Rezende MU, Campos Gurgel HM, Pereira Ocampos G, De Campos GC, Frucchi R, Pailo AF, et al. Improvements in hip osteoarthritis with lavage, triamcinolona and Hyal G-F20. Acta Ortop Bras. 2020;28(6):280-6.
7. Pogliacomi F, Schiavi P, Paraskevopoulos A, Leigheb M, Pedrazzini A, Ceccarelli F, et al. When is indicated viscosupplementation in hip osteoarthritis? Acta Biomed. 2018;90(1-S):67-74.
8. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum. 2001;45(5):453-61.
9. Conrozier T, Vignon E. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis? Clin Exp Rheumatol. 2005;23(5):711-6.
10. Mauro GL, Scaturro D, Sanfilippo A, Benedetti MG. Intra-articular hyaluronic acid injections for hip osteoarthritis. J Biol Regul Homeost Agents. 2018;32(5):1303-9.
11. Liao YY, Lin T, Zhu HX, Shi MM, Yan SG. Intra-articular viscosupplementation for patients with hip osteoarthritis: A meta-analysis and systematic review. Med Sci Monit. 2019;25:6436-45.
12. Schiavi P, Calderazzi F, Pedrini MF, Tacci F, Vaienti E, Pobliacomi F. Efficacy and safety of viscosupplementation with hyaluronic acid for hip osteoarthritis: results from a cross-sectional study with a minimum follow-up of 4 years. Acta Biomed. 2020;91(14-S):e2020032.
13. Uson J, Rodriguez-García SC, Castellanos-Moreira R, O’Neil TW, Doherty M, Boesen M, et al. EULAR recommendations of intra-articular therapies. Ann Rheum Dis. 2021;80(10):1299-305.